Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera
Science, 2022 The globally circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern Omicron (B.1.1.529) has a large number of mutations, especially in the spike protein, indicating that recognition by neutralizing antibodies may be ...
A. Muik +16 more
semanticscholar +1 more source
Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection [PDF]
, 2022 Supported by the U.K. Health Security Agency, the U.K. Department of Health and Social Care (with contributions from the governments in Northern Ireland, Wales, and Scotland), the National Institute for Health Research, and grants from the Medical ...
Dhasmana, Devesh J, SIREN Study Group
core +1 more source
Myopericarditis following both BNT162b2 and NVX-CoV2373
Allergy, Asthma & Clinical Immunology, 2022 Abstract Background Myopericarditis is a well reported complication associated with SARS-Cov-2 (COVID-19) infection and vaccinations; particularly with mRNA vaccines (BNT162b2 and mRNA-1273), and in the young male population.
Saima Ahmad +3 more
openaire +3 more sources
Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine
Nature Immunology, 2022 Despite the success of the BNT162b2 mRNA vaccine, the immunological mechanisms that underlie its efficacy are poorly understood. Here we analyzed the innate and adaptive responses to BNT162b2 in mice, and show that immunization stimulated potent antibody
Chunfeng Li +23 more
semanticscholar +1 more source
Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events:A population-based cohort study of 46 million adults in England [PDF]
, 2022 BACKGROUND: Thromboses in unusual locations after the Coronavirus Disease 2019 (COVID-19) vaccine ChAdOx1-S have been reported, although their frequency with vaccines of different types is uncertain at a population level.
,, Whiteley, William N
core +3 more sources
Nature Medicine, 2022 The recent emergence of the SARS-CoV-2 Omicron variant is raising concerns because of its increased transmissibility and its numerous spike mutations, which have the potential to evade neutralizing antibodies elicited by COVID-19 vaccines.
E. Pérez-Then +25 more
semanticscholar +1 more source
Why COVID vaccines for young children (5–11 years) are not essential at this moment in time?
Journal of Pharmaceutical Policy and Practice, 2022 The Joint Committee on Vaccination and Immunisation (JCVI) in UK has recently advised that COVID vaccines in 5–11-year-old children is non-essential. This has created an outrage among some healthcare professionals who believed a mandatory vaccination ...
Hamid A. Merchant
doaj +1 more source
Branch Retinal Vein Occlusion after Messenger RNA-Based COVID-19 Vaccine
Case Reports in Ophthalmology, 2022 Two days after the second dose of the messenger RNA-based COVID-19 vaccine (BNT162b2), a healthy 38-year-old man developed branch retinal vein occlusion (BRVO) in his left eye (OS).
Kazunobu Sugihara +2 more
doaj +1 more source
Acute myocarditis following administration of BNT162b2 vaccine
IDCases, 2021 The wide use of vaccines was linked with rare but serious complications in adults, causing a global concern. Here, we describe a young male patient, who presented with acute myocarditis, three days after the second dose of BNT162b2 vaccine.
Mhd Baraa Habib +4 more
openaire +3 more sources
Clinical development of variant-adapted BNT162b2 COVID-19 vaccines: the early Omicron era
Expert Review of Vaccines, 2023 Introduction The Omicron BA.1 variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and subsequent sub-lineages exhibit partial escape from neutralizing antibodies elicited by vaccines containing or encoding wild-type spike protein.
Shanti Pather +3 more
doaj +1 more source